Fms-like tyrosine kinase-3 ligand (Flt3L) uniquely binds the Flt3 (CD135) receptor expressed on hematopoietic stem cells (HSCs), early progenitor cells, immature thymocytes and steady-state dendritic ...
Advances in precision oncology have transformed cancer treatment, offering life-saving therapies to patients with limited options. However, the development of personalized medicine introduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results